We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
-13.57%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$84.5B
AUM Growth
-$745M
Cap. Flow
+$13.7B
Cap. Flow %
16.26%
Top 10 Hldgs %
10.97%
Holding
4,738
New
695
Increased
1,955
Reduced
1,481
Closed
562

Sector Composition

Rank Sector Weight
1 Healthcare 19.41%
2 Technology 16.8%
3 Consumer Staples 11.12%
4 Consumer Discretionary 10.11%
5 Financials 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPRB
3526
Spruce Biosciences
SPRB
$118M
$263K ﹤0.01%
2,019
+530
+36% +$67.9K
DAVA icon
3527
Endava
DAVA
$158M
$261K ﹤0.01%
2,960
-16,000
-84% -$1.67M
GTH
3528
DELISTED
Genetron Holdings Limited ADS
GTH
$261K ﹤0.01%
51,090
+7,990
+19% +$41K
MYPS icon
3529
PLAYSTUDIOS Inc
MYPS
$77.9M
$260K ﹤0.01%
+60,800
New +$330K
EWTX icon
3530
Edgewise Therapeutics
EWTX
$4.13B
$259K ﹤0.01%
+32,600
New +$246K
PCY icon
3531
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.38B
$259K ﹤0.01%
14,000
-196,117
-93% -$3.98M
RNDB
3532
DELISTED
Randolph Bancorp, Inc. Common Stock
RNDB
$259K ﹤0.01%
+9,800
New +$257K
BLPH
3533
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$258K ﹤0.01%
209,399
+24,100
+13% +$32.2K
ASYS icon
3534
Amtech Systems
ASYS
$268M
$257K ﹤0.01%
35,196
-14,900
-30% -$129K
XMMO icon
3535
Invesco S&P MidCap Momentum ETF
XMMO
$7.11B
$256K ﹤0.01%
+3,600
New +$288K
VCSA
3536
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$256K ﹤0.01%
+4,450
New +$469K
EFOI icon
3537
Energy Focus
EFOI
$19.4M
$255K ﹤0.01%
+28,059
New +$259K
FTHM icon
3538
Fathom Holdings
FTHM
$26.4M
$255K ﹤0.01%
+32,500
New +$276K
IYT icon
3539
iShares US Transportation ETF
IYT
$2.26B
$255K ﹤0.01%
+4,800
New +$279K
SGHT icon
3540
Sight Sciences
SGHT
$286M
$254K ﹤0.01%
28,300
-700
-2% -$6.16K
FNCB
3541
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
$253K ﹤0.01%
31,600
-17,900
-36% -$149K
EVI icon
3542
EVI Industries
EVI
$181M
$252K ﹤0.01%
+25,197
New +$335K
BYFC icon
3543
Broadway Financial
BYFC
$93.8M
$251K ﹤0.01%
29,627
-2,265
-7% -$27K
EJH icon
3544
E-Home Household Service Holdings
EJH
$3.68M
0
FBND icon
3545
Fidelity Total Bond ETF
FBND
$26.9B
$251K ﹤0.01%
5,390
-3,010
-36% -$143K
NBSE
3546
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$251K ﹤0.01%
11,957
+1,215
+11% +$28.5K
APLT
3547
DELISTED
Applied Therapeutics
APLT
$250K ﹤0.01%
264,178
-18,022
-6% -$29.5K
APVO icon
3548
Aptevo Therapeutics
APVO
$5.12M
0
AUBN icon
3549
Auburn National Bancorp
AUBN
$91.3M
$250K ﹤0.01%
9,241
-2,300
-20% -$70K
CYCN icon
3550
Cyclerion Therapeutics
CYCN
$14.9M
$250K ﹤0.01%
22,804
+7,676
+51% +$110K

Similar funds

Renaissance Technologies's Q2 2022 Portfolio in Review

As of Q2 2022, Renaissance Technologies held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Renaissance Technologies deployed $13.7B of net new capital in Q2 2022, opening 695 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.

  • Renaissance Technologies's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
  • Renaissance Technologies added most to Chevron in Q2 2022, an estimated $820M increase.
  • Renaissance Technologies's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
  • Renaissance Technologies fully exited Amazon in Q2 2022, selling an estimated $675M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
  • Renaissance Technologies opened 695 new positions and closed 562 in Q2 2022.
  • Renaissance Technologies's portfolio value fell 0.87% quarter-over-quarter to $84.5B.

Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.